Terug
Dagbereik
€ 58,74
€ 65,67
52-Weeksbereik
€ 26,56
€ 83,31
Volume
733.538
50D / 200D Gem.
€ 69,74
/
€ 54,65
Vorige Slotkoers
€ 62,65
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -34,2 | 0,4 |
| P/B | 74,2 | 2,9 |
| ROE % | -133,3 | 3,7 |
| Net Margin % | -24,2 | 3,8 |
| Rev Growth 5Y % | 13,6 | 10,0 |
| D/E | 11,2 | 0,2 |
Belangrijkste Punten
Revenue grew 13,61% annually over 5 years — strong growth
Debt/Equity of 11,23 — high leverage
Negative free cash flow of -56,94M
PEG of 0,99 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 13,53%
Capital efficient — spends only 2,87% of revenue on capex
Groei
Revenue Growth (5Y)
13,61%
Revenue (1Y)27,14%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-133,25%
ROIC-10,16%
Net Margin-24,19%
Op. Margin-18,48%
Veiligheid
Debt / Equity
11,23
Current Ratio3,04
Interest Coverage-1,54
Waardering
P/E Ratio
-34,23
P/B Ratio74,23
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 27,14% | Revenue Growth (3Y) | 13,05% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 13,61% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 211,08M | Net Income (TTM) | -51,06M |
| ROE | -133,25% | ROA | -14,30% |
| Gross Margin | 69,32% | Operating Margin | -18,48% |
| Net Margin | -24,19% | Free Cash Flow (TTM) | -56,94M |
| ROIC | -10,16% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 11,23 | Current Ratio | 3,04 |
| Interest Coverage | -1,54 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -34,23 | P/B Ratio | 74,23 |
| P/S Ratio | 8,28 | PEG Ratio | 0,99 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,75B | Enterprise Value | 1,94B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 211,08M | 166,03M | 165,15M | 161,70M | 126,68M |
| Net Income | -51,06M | -84,60M | -78,50M | -75,21M | -41,14M |
| EPS (Diluted) | -1,72 | -3,00 | -3,07 | -3,08 | -1,72 |
| Gross Profit | 146,31M | 109,53M | 106,98M | 106,60M | 85,40M |
| Operating Income | -39,01M | -49,99M | -65,03M | -39,66M | -25,14M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 357,17M | 346,83M | 268,64M | 211,06M | 139,53M |
| Total Liabilities | 333,62M | 293,74M | 250,25M | 219,25M | 88,79M |
| Shareholders' Equity | 23,55M | 53,10M | 18,40M | -8,19M | 50,74M |
| Total Debt | 264,47M | 225,29M | 192,22M | 179,35M | 54,21M |
| Cash & Equivalents | 75,57M | 90,35M | 40,04M | 66,36M | 53,42M |
| Current Assets | 249,94M | 243,04M | 174,90M | 149,90M | 113,27M |
| Current Liabilities | 82,14M | 68,28M | 57,15M | 38,96M | 31,89M |